Advanced Oncology Chemistry
Oncology Intermediates (N-1 / N-2)
Specialised in advanced N-1 / N-2 oncology intermediate chemistry — developed and supplied at commercial scale.
| Product | Therapeutic Use | Regulatory / Grade |
|---|---|---|
| 6,7-Dimethoxy-4-chloroquinoline | Cabozantinib / Tivozanib | 35654-56-9 |
| 2-Amino-N-(2-chloro-6-methylphenyl)-5-thiazolecarboxamide | Dasatinib (N-2) | 302964-24-5 |
| N-(2-Chloro-6-methylphenyl)-2-[(6-chloro-2-methyl-4-pyrimidinyl)amino]-5-thiazolecarboxamide | Dasatinib (N-1) | 302964-08-5 |
| 3-Aminophenylacetylene | Erlotinib side chain | 54060-30-9 |
| 6,7-Bis-(2-methoxyethoxy)-4(3H)-quinazolinone | Erlotinib (N-2) | 179688-29-0 |
| R-3-(4-Phenoxy-phenyl)-1-piperidin-3-yl-1H-pyrazolo[3,4-d]pyrimidin-4-amine | Ibrutinib (N-1) | 1022150-12-4 |
| 3-(4-Phenoxy Phenyl)-1H-pyrazole[3,4-d]pyrimidin-4-Amine | Ibrutinib (N-2) | 330786-24-8 |
| Methyl-(S)-N-Ethoxycarbonyl-4-Amino phenylalaninate | Melphalan (N-1) | 169472-17-7 |
| 4-Amino-L-phenyl-N-phthalylalanine ethyl ester | Melphalan (N-2) | 74743-23-0 |
| N-(2-chloropyrimidin-4-yl)-N,2,3-trimethylindazol-6-amine | Pazopanib (N-1) | 444731-75-3 |
| 5-Amino-2-methyl-benzenesulfonamide | Pazopanib side chain | 6973-07-9 |
| 4-[2-(2-Amino-4,7-dihydro-4-oxo-1H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoic acid | Pemetrexed (N-2) | 137281-39-1 |
| 4-(4-Aminophenoxy)-N-methylpyridine-2-carboxamide | Sorafenib (N-2) | 284462-37-9 |
| Methyl-4-(4-aminophenyl)butyrate | Chlorambucil (N-2) | 20637-09-6 |
| Methyl-4-{4-[Bis(2-Hydroxyethyl)Amino]Phenyl}Butanoate | Chlorambucil (N-1) | 130198-76-4 |
| Product | Therapeutic Use | Regulatory / Grade |
|---|---|---|
| 3-(4-methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)aniline | Nilotinib (N-1) | 641571-11-1 |
| 6-Bromo-2-chloro-8-cyclopentyl-5-methylpyrido[2,3-d]pyrimidin-7(8H)-one | Palbociclib (N-1) | 1016636-76-2 |
| tert-Butyl 4-(6-aminopyridin-3-yl)piperazine-1-carboxylate | Palbociclib (N-2) | 571188-59-5 |
| Beta-D-Ribofuranose 1,2,3,5-tetraacetate | Azacitidine (N-1) | 13035-61-5 |
| 5-Azacytosine | Azacitidine (N-2) | 931-86-2 |
| 1,2,3-Triacetyl-5-deoxy-D-ribose | Capecitabine (N-1) | 62211-93-2 |
| 4-Chloro-7H-pyrrolo[2,3-d]pyrimidine | Ruxolitinib (N-1) | 3680-69-1 |
| 4-(4,5-Dihydro-1H-pyrazol-4-yl)-7-((2-(trimethylsilyl)ethoxy)methyl)-7H-pyrrolo[2,3-d]pyrimidine | Ruxolitinib (N-2) | 941685-27-4 |
| N-(4-cyano-3-(trifluoromethyl)phenyl)-2-methyloxirane-2-carboxamide | Bicalutamide (N-1) | 90357-51-0 |
| N-[3-Chloro-4-(3-fluorobenzyloxy)phenyl]-6-iodoquinazolin-4-amine | Lapatinib (N-1) | 231278-20-9 |
| 5-[Bis(2-hydroxyethyl)amino]-1-methyl-1H-benzimidazole-2-butanoic acid ethyl ester | Bendamustine (N-1) | 3543-74-6 |
| 1-Methyl-5-amino-1H-benzimidazole-2-butanoic acid ethyl ester | Bendamustine (N-2) | 3543-73-5 |
| 2,6-Dioxopiperidine-3-ammonium chloride | Thalidomide / Pomalidomide / Lenalidomide (N-2) | 24666-56-6 |
| Methyl 2-bromomethyl-3-nitrobenzoate | Lenalidomide (N-2) | 98475-07-1 |
| 4-Methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]benzoic acid | Nilotinib (N-2) | 641569-94-0 |